These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28082038)
1. Design, synthesis and biological activity evaluation of novel 2,6-difluorobenzamide derivatives through FtsZ inhibition. Bi F; Guo L; Wang Y; Venter H; Semple SJ; Liu F; Ma S Bioorg Med Chem Lett; 2017 Feb; 27(4):958-962. PubMed ID: 28082038 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ. Ma S; Cong C; Meng X; Cao S; Yang H; Guo Y; Lu X; Ma S Bioorg Med Chem Lett; 2013 Jul; 23(14):4076-9. PubMed ID: 23770057 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and structure-based optimization of novel isoxazole-containing benzamide derivatives as FtsZ modulators. Bi F; Song D; Zhang N; Liu Z; Gu X; Hu C; Cai X; Venter H; Ma S Eur J Med Chem; 2018 Nov; 159():90-103. PubMed ID: 30268826 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antibacterial activity of 5-methylphenanthridium derivatives as FtsZ inhibitors. Liu F; Venter H; Bi F; Semple SJ; Liu J; Jin C; Ma S Bioorg Med Chem Lett; 2017 Aug; 27(15):3399-3402. PubMed ID: 28633894 [TBL] [Abstract][Full Text] [Related]
5. Benzodioxane-Benzamides as Antibacterial Agents: Computational and SAR Studies to Evaluate the Influence of the 7-Substitution in FtsZ Interaction. Straniero V; Sebastián-Pérez V; Hrast M; Zanotto C; Casiraghi A; Suigo L; Zdovc I; Radaelli A; De Giuli Morghen C; Valoti E ChemMedChem; 2020 Jan; 15(2):195-209. PubMed ID: 31750973 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus. Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biological Evaluation of Novel FtsZ-targeted 3-arylalkoxy-2,6-difluorobenzamides as Potential Antimicrobial Agents. Qiang S; Wang C; Venter H; Li X; Wang Y; Guo L; Ma R; Ma S Chem Biol Drug Des; 2016 Feb; 87(2):257-64. PubMed ID: 26348110 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ. Stokes NR; Baker N; Bennett JM; Chauhan PK; Collins I; Davies DT; Gavade M; Kumar D; Lancett P; Macdonald R; Macleod L; Mahajan A; Mitchell JP; Nayal N; Nayal YN; Pitt GR; Singh M; Yadav A; Srivastava A; Czaplewski LG; Haydon DJ Bioorg Med Chem Lett; 2014 Jan; 24(1):353-9. PubMed ID: 24287381 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors. Wang Y; Yan M; Ma R; Ma S Arch Pharm (Weinheim); 2015 Apr; 348(4):266-74. PubMed ID: 25773717 [TBL] [Abstract][Full Text] [Related]
10. Benzodioxane-benzamides as new bacterial cell division inhibitors. Chiodini G; Pallavicini M; Zanotto C; Bissa M; Radaelli A; Straniero V; Bolchi C; Fumagalli L; Ruggeri P; De Giuli Morghen C; Valoti E Eur J Med Chem; 2015 Jan; 89():252-65. PubMed ID: 25462242 [TBL] [Abstract][Full Text] [Related]
11. 2,6-Difluorobenzamide Inhibitors of Bacterial Cell Division Protein FtsZ: Design, Synthesis, and Structure-Activity Relationships. Straniero V; Zanotto C; Straniero L; Casiraghi A; Duga S; Radaelli A; De Giuli Morghen C; Valoti E ChemMedChem; 2017 Aug; 12(16):1303-1318. PubMed ID: 28586174 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antibacterial evaluation of novel 11-O-aralkylcarbamoyl-3-O-descladinosylclarithromycin derivatives. Jia L; Wang Y; Wang Y; Qin Y; Hu C; Sheng J; Ma S Bioorg Med Chem Lett; 2018 Aug; 28(14):2471-2476. PubMed ID: 29880401 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activity of novel 3-O-arylalkylcarbamoyl-3-O-descladinosyl-9-O-(2-chlorobenzyl)oxime clarithromycin derivatives. Qin Y; Qiang S; Ji S; Liu Z; Hu C; Ma S Bioorg Med Chem Lett; 2018 Nov; 28(20):3324-3328. PubMed ID: 30219527 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents. Song D; Zhang N; Zhang P; Zhang N; Chen W; Zhang L; Guo T; Gu X; Ma S Eur J Med Chem; 2021 Oct; 221():113480. PubMed ID: 33964649 [TBL] [Abstract][Full Text] [Related]
15. A Carbocyclic Curcumin Inhibits Proliferation of Gram-Positive Bacteria by Targeting FtsZ. Groundwater PW; Narlawar R; Liao VW; Bhattacharya A; Srivastava S; Kunal K; Doddareddy M; Oza PM; Mamidi R; Marrs EC; Perry JD; Hibbs DE; Panda D Biochemistry; 2017 Jan; 56(3):514-524. PubMed ID: 28002947 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and antibacterial activity of cinnamaldehyde derivatives as inhibitors of the bacterial cell division protein FtsZ. Li X; Sheng J; Huang G; Ma R; Yin F; Song D; Zhao C; Ma S Eur J Med Chem; 2015 Jun; 97():32-41. PubMed ID: 25938986 [TBL] [Abstract][Full Text] [Related]
17. A combined CoMFA and CoMSIA 3D-QSAR study of benzamide type antibacterial inhibitors of the FtsZ protein in drug-resistant Staphylococcus aureus. Andrades J; Campanini J; Vásquez D; Silvestri C; Morales C; Romero J; Mella J SAR QSAR Environ Res; 2015; 26(11):925-42. PubMed ID: 26505124 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria. Kaul M; Zhang Y; Parhi AK; Lavoie EJ; Pilch DS Biochem Pharmacol; 2014 Jun; 89(3):321-8. PubMed ID: 24637241 [TBL] [Abstract][Full Text] [Related]